Pharmacological neuroprotection after perinatal asphyxia. - Test2 - elhamkhani - TriplyDB

Pharmacological neuroprotection after perinatal asphyxia.

Pharmacological neuroprotection after perinatal asphyxia.

http://www.wikidata.org/entity/Q37778834

about

Selective protection of the cerebellum against intracerebroventricular LPS is mediated by local melatonin synthesis Pathophysiology of perinatal asphyxia: can we predict and improve individual outcomes?Treatment advances in neonatal neuroprotection and neurointensive care.12/15-lipoxygenase expression is increased in oligodendrocytes and microglia of periventricular leukomalacia Antenatal allopurinol reduces hippocampal brain damage after acute birth asphyxia in late gestation fetal sheep.Perinatal stroke: a case-based review.Hyperbaric oxygen treatment promotes neural stem cell proliferation in the subventricular zone of neonatal rats with hypoxic-ischemic brain damage 2-Iminobiotin Superimposed on Hypothermia Protects Human Neuronal Cells from Hypoxia-Induced Cell Damage: An in Vitro Study.Rapid target allopurinol concentrations in the hypoxic fetus after maternal administration during labour.NF-κB activity in perinatal brain during infectious and hypoxic-ischemic insults revealed by a reporter mouse.

P2860

Q35123174-DF54CC5B-FFB5-4EA5-8CB2-74D658C7E05A Q36117886-6B418FC6-D7D1-4D11-9A35-31D343C6A27B Q37131984-5779308D-4C69-4C3D-B14C-E758EFF708FC Q37385634-0AA39BDB-A675-4C0F-80AB-87CFD65BAED2 Q37430173-EB979474-33BE-4054-A087-40318A1601F7 Q37894568-DE4D06D5-5B49-406C-94F9-0FAC9772CEE8 Q42182387-BCCDC7B0-F7C2-49C9-B01F-37F37D42987A Q48527801-3FDD4180-3C07-4326-9256-D02511480193 Q50482094-F1537570-7DAB-4BDF-B297-EEC2E0CE4B74 Q50508300-D01D0FC0-95C7-4384-9FD2-57007F3437EB

P2860

Pharmacological neuroprotection after perinatal asphyxia.

http://www.wikidata.org/entity/Q37778834

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pharmacological neuroprotection after perinatal asphyxia.

@en

Pharmacological neuroprotection after perinatal asphyxia.

@nl

type

label

Pharmacological neuroprotection after perinatal asphyxia.

@en

Pharmacological neuroprotection after perinatal asphyxia.

@nl

prefLabel

Pharmacological neuroprotection after perinatal asphyxia.

@en

Pharmacological neuroprotection after perinatal asphyxia.

@nl

P1433

Q37778834-3772B5F1-3FF6-4E3A-A575-4061918A0440

P1476

Q37778834-FFC0ED18-E2B6-4EBD-9B3B-E2921E24FE92

P2093

Q37778834-FC4EF655-3765-48A2-B96C-DCDD86FB44B3

Q37778834-FF58F5E0-0562-4BB4-BAB8-0909008A477E

P2860

Q37778834-009F13A7-7D1C-4A62-93D8-B25CC29127A3

Q37778834-065C250C-7C3A-4C6C-A2AC-4B85B86F63DB

Q37778834-0D78DCF2-0A61-4FCC-B92D-C962E505D0D7

Q37778834-133B56B2-269A-4A69-8F83-CA380E29E291

Q37778834-1E8752B4-E884-4C19-8C8D-A0887EEE339E

Q37778834-40148392-E336-4096-8310-2D6EABB206B7

Q37778834-50B8FB49-70A8-4238-9EAB-C60B56B5B2AC

Q37778834-5D36C7F9-94A5-48FF-817D-EE55BEB53640

Q37778834-686C5805-D48D-4306-9087-1A464F2F882D

Q37778834-746AE4F1-2042-4E60-93D1-569F1E780151

P304

Q37778834-E4D4B08E-6662-4875-89A0-A476F4331C08

P31

Q37778834-A1D8B806-C1CE-4ACB-AC89-B8579AA9F497

P356

Q37778834-D45A81D0-34E6-4045-AB66-DC396E096E30

P478

Q37778834-4FDBA142-24FC-4BEE-89F5-CC9460BDE15D

P577

Q37778834-2E26384E-5913-494F-BF7A-A9585CCF3BA8

P5875

Q37778834-F37E89EE-A4E5-4B42-9CAE-E50FBEE33A1C

P698

Q37778834-A3E6E85C-7AA4-4092-BC3B-C5959442C206

P921

Q37778834-7C6D75C1-0F23-452F-8323-32721C3CBCFB

Q37778834-FAA53D72-735D-4065-86F9-9911A0999A87

P356

14767058.2010.505052

P1433

Journal of Maternal-Fetal and Neonatal Medicine

P1476

Pharmacological neuroprotection after perinatal asphyxia.

@en

P2093

Frank van Bel

http://www.w3.org/2001/XMLSchema#string

Xiyong Fan

http://www.w3.org/2001/XMLSchema#string

P2860

Neuroprotective properties and mechanisms of erythropoietin in in vitro and in vivo experimental models for hypoxia/ischemia.

Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke.

Attenuation of brain injury and reduction of neuron-specific enolase by nicardipine in systemic circulation following focal ischemia and reperfusion in a rat model.

Brain injury expands the numbers of neural stem cells and progenitors in the SVZ by enhancing their responsiveness to EGF

Intranasal administration of IGF-1 attenuates hypoxic-ischemic brain injury in neonatal rats.

Early postnatal allopurinol does not improve short term outcome after severe birth asphyxia.

Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration.

Role of caspase-3 activation in cerebral ischemia-induced neurodegeneration in adult and neonatal brain.

Inhibition of nNOS and iNOS following hypoxia-ischaemia improves long-term outcome but does not influence the inflammatory response in the neonatal rat brain.

Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats.

P304

17-19

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/14767058.2010.505052

http://www.w3.org/2001/XMLSchema#string

P478

23 Suppl 3

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45582216

http://www.w3.org/2001/XMLSchema#string

P698

20695757

http://www.w3.org/2001/XMLSchema#string

P921